Treatment of bed sore with Platelet rich plasma in patients with spinal cord injury
- Conditions
- Health Condition 1: null- Spinal cord injured
- Registration Number
- CTRI/2021/09/036188
- Lead Sponsor
- Indian Council of Medical Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
1. Participants with age more than 18 and less than 65 years.
2. Participants or close relative must be able to give voluntary written consent.
3. Participants with sacral PU with <3m duration.
4. Pressure ulcer of grade III & IV will be included in the study.
5. Participant who hospitalized for rehabilitation at ISIC will be included in the study.
1. Mental, psychiatric or cognitive disorder and /or pre-existing medical condition that might interfere with the outcomes.
2. Pressure sores associated with osteomyelitis, malignancy, leprosy and HIV (+ve)
3. Platelet dysfunction
4. Arterial origin of the cutaneous ulcers.
5. Active vasculitis,
6. Systemic lupus erythematosus, cryoglobulinemia,
7. Hematological abnormality or any coagulation abnormalities.
8. Current use of anticoagulants and/or treatment with immunosuppressant drugs;
9. Serum hemoglobin concentration <11 g/dL or hematocrit <34%;
10. Participant taking drug which might interfere with the study intervention like Anti- neoplastic drugs, steroids, antibiotics etc.
11. Drug or alcohol abuse..
12. Patient who smokes will be excluded from the study.
13. Diabetes (controlled/ Uncontrolled), uncontrolled hypertension, autoimmune disease, renal failure.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Size of pressure ulcer (percentage of surface area healed).Timepoint: 5 week and 3 month
- Secondary Outcome Measures
Name Time Method Pressure Ulcers Scale for Healing (PUSH) <br/ ><br>Depth of pressure ulcers <br/ ><br>Quality of Life using SF 36 <br/ ><br>4. Participant impression of change using visual analogue scale (VAS) <br/ ><br>5. Clinician impression of change using VAS <br/ ><br>6. Participantsâ?? satisfaction using VAS <br/ ><br>7. Histo-pathological resultsTimepoint: 3 month from the day of randomization